| Stage | IQV | % of rev | QTWO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.4B | 100.00% | $226M | 100.00% | IQV ×19.61 |
| Gross profit | $1.5B | 33.83% | $135M | 59.73% | QTWO +25.9pp |
| Operating income | $572M | 12.92% | $34M | 15.04% | QTWO +2.1pp |
| Pre-tax income | $386M | 8.72% | $34M | 15.21% | QTWO +6.5pp |
| Net income | $352M | 7.95% | $33M | 14.71% | QTWO +6.8pp |
| Stage | IQV | QTWO | Gap · A − B |
|---|---|---|---|
| Revenue | $4.4B100.00% | $226M100.00% | IQV ×19.61 |
| Gross profit | 33.83%$1.5B | 59.73%$135M | QTWO +25.9pp |
| Operating income | 12.92%$572M | 15.04%$34M | QTWO +2.1pp |
| Pre-tax income | 8.72%$386M | 15.21%$34M | QTWO +6.5pp |
| Net income |
| 7.95%$352M |
| 14.71%$33M |
| QTWO +6.8pp |